Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

29.36
+0.74502.60%
Post-market: 29.450.0900+0.31%16:25 EDT
Volume:4.44M
Turnover:131.44M
Market Cap:3.30B
PE:-25.46
High:30.28
Open:29.19
Low:29.09
Close:28.62
Loading ...

US STOCKS-Tech stocks power Wall St higher after Trump's tariff relief for some electronics

Reuters
·
14 Apr

Viking, Structure rally after Pfizer halts obesity drug development

TIPRANKS
·
14 Apr

Obesity Drugmakers Shares Rise After Pfizer Ends Development of Weight-Loss Pill Danuglipron

Reuters
·
14 Apr

Shares of Eli Lilly up 1.8%, Drug Developer Viking Therapeutics Shares Rise 13%

THOMSON REUTERS
·
14 Apr

Shares of U.S. Listed Obesity Drugmakers Rise After Pfizer to End Development of Its Experimental Weight-Loss Pill

THOMSON REUTERS
·
14 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Pfizer, Best Buy

Reuters
·
14 Apr

BUZZ-Obesity drugmakers rise after Pfizer ends development of weight-loss pill

Reuters
·
14 Apr

Shares of Eli Lilly up 2%, Drug Developer Viking Therapeutics Shares Rise 16.5%

THOMSON REUTERS
·
14 Apr

Shares of U.S. Listed Obesity Drugmakers Rise Premarket After Pfizer to End Development of Its Experimental Weight-Loss Pill

THOMSON REUTERS
·
14 Apr

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?

Motley Fool
·
10 Apr

Viking Therapeutics Initiated at Neutral by Goldman Sachs

Dow Jones
·
09 Apr

LLY vs. NVO: Which Weight-Loss Drug Stock is a Stronger Play Now?

Zacks
·
08 Apr

Goldman Sachs Initiates Viking Therapeutics With Neutral Rating, $30 Price Target

MT Newswires Live
·
08 Apr

Viking Therapeutics initiated with a Neutral at Goldman Sachs

TIPRANKS
·
08 Apr

Cautious Hold Rating for Viking Therapeutics Amid Competitive Obesity Market Challenges

TIPRANKS
·
08 Apr

NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare

Zacks
·
07 Apr

Viking Therapeutics Director Makes a Bold Stock Purchase!

TIPRANKS
·
03 Apr

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

Motley Fool
·
02 Apr

Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)

TIPRANKS
·
31 Mar

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Zacks
·
27 Mar